How does treatment management change with a positive intramammary lymph node in the setting of a negative axilla, with the inclusion of these as N1 node in the AJCC 8th edition?

Topics: Breast Cancer • Radiation Oncology

Answer from: Radiation Oncologist at Community Practice

I don’t think anything would change for management as I would treat the same RT field and a med onc would follow the same principle of using genomic assay (or phenotype) to decide about systemic treatment.

Comments

Radiation Oncologist at Confluence Health
So in the patient with a positive intramammary nod...

Radiation Oncologist at Varian Medical Systems/Allegheny health network
If they have positive intramammary node and negati...

Radiation Oncologist at Confluence Health
No axillary "sentinel lymph node evaluation" was p...

Radiation Oncologist at Varian Medical Systems/Allegheny health network
Yes ideally sentinel node evaluation should be per...

Related Questions